Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1141 AL 1155

Effect of Treadmill Training Interventions on Spatiotemporal Gait Parameters in Older Adults with Neurological Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Bishnoi A, Lee R, Hu Y, Mahoney JR, Hernandez ME.

Int J Environ Res Public Health. 2022 Feb 28;19(5):2824. doi: 10.3390/ijerph19052824.

Internet of Things Technologies and Machine Learning Methods for Parkinson's Disease Diagnosis, Monitoring and Management: A Systematic Review

Giannakopoulou KM, Roussaki I, Demestichas K.

Sensors (Basel). 2022 Feb 24;22(5):1799. doi: 10.3390/s22051799.

Striatal synaptic adaptations in Parkinson's disease

Shen W, Zhai S, Surmeier DJ.

Neurobiol Dis. 2022 Jun 1;167:105686. doi: 10.1016/j.nbd.2022.105686. Epub 2022 Mar 8.

Editorial: Tremors

Truong D, Shaikh A, Hallett M.

J Neurol Sci. 2022 Apr 15;435:120189. doi: 10.1016/j.jns.2022.120189. Epub 2022 Feb 19.

Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies

Gibbons CH, Freeman R, Bellaire B, Adler CH, Moore D, Levine T.

Biomark Med. 2022 May;16(7):499-509. doi: 10.2217/bmm-2021-0646. Epub 2022 Mar 11.

Bayesian Interpretation of Essential Tremor Plus

Elble RJ.

J Clin Neurol. 2022 Mar;18(2):127-139. doi: 10.3988/jcn.2022.18.2.127.

Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies

Calisti F, Cattaneo A, Calabrese M, Mao Y, Tocco M, Pikalov A, Goldman R.

Int Clin Psychopharmacol. 2022 Sep 1;37(5):215-222. doi: 10.1097/YIC.0000000000000398. Epub 2022 Mar 9.

Beneficial Effects of Spirulina Consumption on Brain Health

Trotta T, Porro C, Cianciulli A, Panaro MA.

Nutrients. 2022 Feb 5;14(3):676. doi: 10.3390/nu14030676.

The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease

Chakkittukandiyil A, Sajini DV, Karuppaiah A, Selvaraj D.

Neurochem Int. 2022 Jun;156:105325. doi: 10.1016/j.neuint.2022.105325. Epub 2022 Mar 9.

Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial

Chaudhuri KR, Odin P, Ferreira JJ, Antonini A, Rascol O, Kurtis MM, Storch A, Bannister K, Soares-da-Silva P, Costa R, Magalhães D, Rocha JF.

BMC Neurol. 2022 Mar 12;22(1):88. doi: 10.1186/s12883-022-02602-8.

Medications used to treat tremors

Frei K, Truong DD.

J Neurol Sci. 2022 Apr 15;435:120194. doi: 10.1016/j.jns.2022.120194. Epub 2022 Feb 19.

Problems and controversies in tremor classification

Louis ED, Bain PG.

J Neurol Sci. 2022 Apr 15;435:120204. doi: 10.1016/j.jns.2022.120204. Epub 2022 Feb 19.

Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson's disease

Kostrzewa RM.

J Neural Transm (Vienna). 2022 Jun;129(5-6):445-461. doi: 10.1007/s00702-022-02479-4. Epub 2022 Mar 12.

Comparison of commercially available antibodies for the detection of phosphorylated alpha-synuclein in primary culture of ENS

Lassozé S, de Guilhem de Lataillade A, Oullier T, Neunslist M, Leclair-Visonneau L, Derkinderen P, Paillusson S.

Neurogastroenterol Motil. 2022 Jun;34(6):e14354. doi: 10.1111/nmo.14354. Epub 2022 Mar 13.

Steroid Sulfation in Neurodegenerative Diseases

Vitku J, Hill M, Kolatorova L, Kubala Havrdova E, Kancheva R.

Front Mol Biosci. 2022 Feb 23;9:839887. doi: 10.3389/fmolb.2022.839887. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias